As we enter 2022, clinical trials continue to forge ahead with the latest innovations and discoveries to ensure transformational healthcare for everyo...
Navitas Life Science's rich legacy of experience and expertise helps us serve as trusted advisors and provide tailored solutions grounded in industry ...
Navitas Life Sciences has been successfully supporting the development of therapeutic treatment towards COVID-19 through our multifaceted end to end s...
Established in 2001, our networks community is the place to discuss trends, insights, and future solutions. There is a considerable widening of the ap...
Human Gene therapy is a technique associated with modification or manipulation of gene expression for therapeutic purposes. Luxurna was the first huma...
Technology has revolutionized the healthcare continuum, altering patient safety worldwide, while lowering costs and time. Recent reports have estimate...
World COPD Day 2021 was celebrated recently, and it brought with it the awareness to find better solutions for Chronic Obstructive Pulmonary Disease (...
The advent of peptides and insulin analogs for the treatment of Diabetes Mellitus has enabled improved management of the disorder. The biosimilars in ...
Small to large pharmas are often faced with regulatory needs that could prolong access of their drug product to the market. Handling such requirements...
Navitas Life Sciences remains committed to transforming clinical trials using technology led innovations, data analytics and the vast experience of ex...
Navitas Clinical Research (a part of Navitas Life Sciences) is a trusted partner to the US Federal Government, non-profits & academia for clinical...
It is World Statistics Day on 20th October, and we would like to highlight how effective biometric support is rising as a top strategic priority for r...
October is breast cancer awareness month, and Navitas Life Sciences continues to RISE consistently to the unique needs of oncology patients. Balancing...
Technology led Navitas Life Sciences amped-up digital initiatives, especially during the pandemic, with the inclusion of innovation, creating fertile ...
There was a considerable change in the clinical trial landscape at the onset of the global epidemic, with the initiation of multiple COVID-19 clinical...
Navitas Life Sciences joins the National Coordination Centre, Indian Pharmacopoeia Commission in celebrating National Pharmacovigilance week 17-23rd S...
Here is how Navitas Life Sciences Defines Key Aspects on Building a resilient Future Recent publications include powerful insights from our team of ex...
Dr. Manish Harsh, Vice President, Clinical Data Services provides key insights about the impact of technology on efficient clinical data management Th...
All about QPPV with Dr Philipp Hofmann, Head of Pharmacovigilance, QPPV, Navitas Life Sciences A Market Authorization Holder (MAH) appoints a Qualifie...
Celebrating 200+ pharmaREADY® customers and 100% satisfied users Marty Boom, Global Head of Regulatory and Safety,Navitas Life Sciences “T...